α2δ-1 subunit of voltage-gated calcium channels drugs for Diabetic Peripheral Neuropathic Pain
2 tracked α2δ-1 subunit of voltage-gated calcium channels drugs in the Diabetic Peripheral Neuropathic Pain race. The class explanation lives on the α2δ-1 subunit of voltage-gated calcium channels page; the full indication pipeline across every mechanism is on the Diabetic Peripheral Neuropathic Pain page.
2 Phase 3
Head-to-head evidence: Crisugabalin vs Mirogabalin